Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Desoximetasone + salicylic acid is a topical combination therapy used for the treatment of inflammatory and hyperkeratotic skin conditions, such as psoriasis and corticosteroid-responsive dermatoses. Desoximetasone is a potent synthetic glucocorticoid that reduces inflammation, redness, and itching by activating natural substances in the skin to suppress immune responses. Salicylic acid acts as a keratolytic agent, softening and loosening dry or scaly skin by breaking down keratin, which helps remove scales and enhances penetration of the corticosteroid component[2][3][7]. This combination leverages both anti-inflammatory (desoximetasone) and exfoliative (salicylic acid) mechanisms to improve symptoms in chronic dermatological disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Desoximetasone + salicylic acid.